These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25322988)
1. Toxic effects of aflatoxin B1 on embryonic development of zebrafish (Danio rerio): potential activity of piceatannol encapsulated chitosan/poly (lactic acid) nanoparticles. Dhanapal J; Ravindrran MB; Baskar SK Anticancer Agents Med Chem; 2015; 15(2):248-57. PubMed ID: 25322988 [TBL] [Abstract][Full Text] [Related]
2. Chitosan/poly (lactic acid)-coated piceatannol nanoparticles exert an in vitro apoptosis activity on liver, lung and breast cancer cell lines. Dhanapal J; Balaraman Ravindrran M Artif Cells Nanomed Biotechnol; 2018; 46(sup1):274-282. PubMed ID: 29298541 [TBL] [Abstract][Full Text] [Related]
3. Chitosan/PLA nanoparticles as a novel carrier for the delivery of anthraquinone: synthesis, characterization and in vitro cytotoxicity evaluation. Jeevitha D; Amarnath K Colloids Surf B Biointerfaces; 2013 Jan; 101():126-34. PubMed ID: 22796782 [TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and transfection efficiency of cationic PEGylated PLA nanoparticles as gene delivery systems. Chen J; Tian B; Yin X; Zhang Y; Hu D; Hu Z; Liu M; Pan Y; Zhao J; Li H; Hou C; Wang J; Zhang Y J Biotechnol; 2007 Jun; 130(2):107-13. PubMed ID: 17467097 [TBL] [Abstract][Full Text] [Related]
5. Poly(lactic acid)/chitosan hybrid nanoparticles for controlled release of anticancer drug. Wang W; Chen S; Zhang L; Wu X; Wang J; Chen JF; Le Y Mater Sci Eng C Mater Biol Appl; 2015 Jan; 46():514-20. PubMed ID: 25492016 [TBL] [Abstract][Full Text] [Related]
6. Chitosan nanoparticles and their Tween 80 modified counterparts disrupt the developmental profile of zebrafish embryos. Yuan Z; Li Y; Hu Y; You J; Higashisaka K; Nagano K; Tsutsumi Y; Gao J Int J Pharm; 2016 Dec; 515(1-2):644-656. PubMed ID: 27826026 [TBL] [Abstract][Full Text] [Related]
7. Poly(lactic acid) nanoparticles coated with combined WGA and water-soluble chitosan for mucosal delivery of β-galactosidase. Sheng Y; He H; Zou H Drug Deliv; 2014 Aug; 21(5):370-8. PubMed ID: 24797098 [TBL] [Abstract][Full Text] [Related]
9. Brain pharmacokinetics of neurotoxin-loaded PLA nanoparticles modified with chitosan after intranasal administration in awake rats. Zhang X; Liu L; Chai G; Zhang X; Li F Drug Dev Ind Pharm; 2013 Nov; 39(11):1618-24. PubMed ID: 24087853 [TBL] [Abstract][Full Text] [Related]
10. Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery. Rajan M; Raj V Carbohydr Polym; 2013 Oct; 98(1):951-8. PubMed ID: 23987433 [TBL] [Abstract][Full Text] [Related]
12. Preparation and in vitro evaluation of thienorphine-loaded PLGA nanoparticles. Yang Y; Xie XY; Mei XG Drug Deliv; 2016; 23(3):787-93. PubMed ID: 24870204 [TBL] [Abstract][Full Text] [Related]
13. [Preparation and in vitro evaluation of brucine-loaded polylacticacid nanoparticles]. Zhao J; Liu Z; Xu J; Yu Y; Feng N Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2322-4. PubMed ID: 20030079 [TBL] [Abstract][Full Text] [Related]
14. [PLA-O-CMC nanoparticles: HGF loading and delivery behaviors in vitro]. Li Z; Chen Z; Chang R Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Apr; 28(2):314-7. PubMed ID: 21604493 [TBL] [Abstract][Full Text] [Related]
15. Accelerating thrombolysis with chitosan-coated plasminogen activators encapsulated in poly-(lactide-co-glycolide) (PLGA) nanoparticles. Chung TW; Wang SS; Tsai WJ Biomaterials; 2008 Jan; 29(2):228-37. PubMed ID: 17953984 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of melatonin entrapped PLA nanoparticles: an oxidative stress and T-cell response using golden hamster. Pandey SK; Haldar C; Vishwas DK; Maiti P J Biomed Mater Res A; 2015 Sep; 103(9):3034-44. PubMed ID: 25727726 [TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system. Arif M; Raja MA; Zeenat S; Chi Z; Liu C J Biomater Sci Polym Ed; 2017 Jan; 28(1):50-62. PubMed ID: 27691398 [TBL] [Abstract][Full Text] [Related]
18. Co-encapsulated resveratrol and quercetin in chitosan and peg modified chitosan nanoparticles: For efficient intra ocular pressure reduction. Natesan S; Pandian S; Ponnusamy C; Palanichamy R; Muthusamy S; Kandasamy R Int J Biol Macromol; 2017 Nov; 104(Pt B):1837-1845. PubMed ID: 28472691 [TBL] [Abstract][Full Text] [Related]
19. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
20. Donepezil-Loaded Nanocarriers for the Treatment of Alzheimer's Disease: Superior Efficacy of Extracellular Vesicles Over Polymeric Nanoparticles. Oliveira Silva R; Counil H; Rabanel JM; Haddad M; Zaouter C; Ben Khedher MR; Patten SA; Ramassamy C Int J Nanomedicine; 2024; 19():1077-1096. PubMed ID: 38317848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]